Industry News
Medical Device Industry News
Dan Cummings Is Appointed Chief Commercial Officer of Precision AQ
Dan Cummings will be responsible for Precision AQ's commercial and go-to-market strategies, with the goal of bringing Precision AQ's comprehensive suite of capabilities to help biopharmaceutical companies advance life-changing therapies to market.
Gestalt Diagnostics Raises $7.5 Million Series A Funding | to Expand AI-Powered Pathology Platform
The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest.
Medical Device News Magazine Press Release Policy
Put Your News Out There!
Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Products
Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery.
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to deliver superior efficiency for vitreoretinal and cataract surgery, while enabling exceptional
Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0.85 per
Carr Tech Corp Celebrates FDA 510(k) Class II Approval of FROG All-in-One Filter Needle
This transformative device advances safety and efficiency in drug preparation, underscoring the startup's journey from solo founder to FDA-cleared innovator.
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
The Decipher Prostate test, already widely used for patients with localized disease, is now the only gene expression test available and covered by Medicare to inform treatment decisions for patients across the full continuum of
The Gut-Brain Axis: How Your Microbiome Could Be Shaping Your Mental Health
Lately, people have started to look at mental health in a much wider way, not just focusing on brain chemicals and medicines. Medication is still a big part of treatment for lots of people, but
Second Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints
Trial achieves positive results in the treatment of persistent atrial fibrillation.
Interim HealthCare Names 2025 Nurse of the Year
Legare Boyle, RN, of Greenville, South Carolina rewarded for compassionate patient care and heroic community service during Hurricane Helene recovery .
Daniel Cracchiolo Institute Opens at Steele Children’s Research Center
Marianne Cracchiolo Mago, CEO of The Steele Foundation: “My father’s name representing the fight to cure pediatric diseases is a momentous opportunity. This cements his legacy and represents a significant moment for our family and
Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous clinical approach that raises throughput for fertility clinics, expands access, and empowers women to plan on their own terms.
CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation
In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at
Vektor Medical Announces Post-Market Study Evaluating Benefit of AI-Powered Analysis to Identify and Ablate Non-Pulmonary Vein AF Targets
vMap is the only FDA-cleared non-invasive AI-powered arrhythmia analysis technology designed to improve, enhance, and accelerate ablation procedures, utilizing data from a standard 12-lead ECG.
Announcing RED® 72 SILVER LABEL | Now Featuring Penumbra’s Latest Engineering Enhancements Designed for Seamless Navigation
The new RED 72 SILVER LABEL with SENDit® Technology has shown a remarkable 50% increase in trackability over the original RED 72 with SENDit Technology.
Global Trauma Devices Market Report by iData Research | Uncovers $1.5B Growth Opportunity Driven by Titanium Implants, Modular Systems, and Surgical Robotics
A new 2025 Global Trauma Devices Market Report reveals critical insights for orthopedic device executives, product strategists, and investors seeking to navigate pricing pressures, material innovations, and shifting surgical practices in the orthopedic trauma sector.
Four Sigmatic Debuts The Last of Us Organic Ground Coffee, Infected with Focus & Energy
Four Sigmatic, the #1 functional coffee brand, announced the debut of The Last Of Us High Caffeine Organic Ground Coffee in collaboration with Sony Pictures Consumer Products. Four Sigmatic’s The Last of Us coffee is
CereVasc’s eShunt® System Gains FDA Breakthrough Designation
"The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces the potential safety and efficacy benefits that have
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
"The EVSS represents a new paradigm in peripheral interventions," said Christopher Haig, Co-Founder and CEO of Efemoral Medical. "It's easy to deploy, has high radial strength, can be made in longer lengths, and offers the